New drug duo tested to fight advanced thyroid cancer
NCT ID NCT07193186
Summary
This study is testing whether combining two drugs, anlotinib and benmelstobart, can help control advanced thyroid cancer that has continued to grow after initial treatment. It is for adults whose cancer cannot be surgically removed or has spread. The main goal is to see how many patients' tumors shrink from the treatment and to monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.